Vanguard Group Inc. Increases Holdings in Doximity, Inc. (NASDAQ:DOCS)

Vanguard Group Inc. raised its stake in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) by 5.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 11,038,475 shares of the company’s stock after buying an additional 616,157 shares during the period. Vanguard Group Inc. owned about 5.94% of Doximity worth $234,236,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Quantbot Technologies LP raised its stake in Doximity by 177.8% during the 3rd quarter. Quantbot Technologies LP now owns 136,782 shares of the company’s stock valued at $2,903,000 after buying an additional 87,546 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Doximity by 10.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 699,066 shares of the company’s stock worth $14,834,000 after purchasing an additional 67,363 shares in the last quarter. Polen Capital Management LLC increased its stake in shares of Doximity by 11.6% in the 3rd quarter. Polen Capital Management LLC now owns 215,037 shares of the company’s stock worth $4,563,000 after purchasing an additional 22,377 shares in the last quarter. HighTower Advisors LLC increased its stake in shares of Doximity by 123.6% in the 3rd quarter. HighTower Advisors LLC now owns 66,000 shares of the company’s stock worth $1,400,000 after purchasing an additional 36,485 shares in the last quarter. Finally, Baillie Gifford & Co. increased its stake in shares of Doximity by 0.9% in the 3rd quarter. Baillie Gifford & Co. now owns 6,656,242 shares of the company’s stock worth $141,245,000 after purchasing an additional 57,078 shares in the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Stock Down 0.3 %

Shares of Doximity stock opened at $26.91 on Friday. The firm has a market cap of $5.02 billion, a price-to-earnings ratio of 40.77, a PEG ratio of 3.62 and a beta of 1.18. Doximity, Inc. has a twelve month low of $19.71 and a twelve month high of $37.10. The business has a 50-day moving average price of $28.41 and a 200-day moving average price of $25.59.

Doximity (NASDAQ:DOCSGet Free Report) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.19 by $0.06. The company had revenue of $135.28 million during the quarter, compared to analyst estimates of $127.46 million. Doximity had a return on equity of 16.08% and a net margin of 29.39%. On average, equities analysts expect that Doximity, Inc. will post 0.72 EPS for the current fiscal year.

Insiders Place Their Bets

In other Doximity news, Director Kira Scherer Wampler sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $28.27, for a total value of $141,350.00. Following the completion of the sale, the director now owns 10,258 shares of the company’s stock, valued at $289,993.66. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 39.40% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

DOCS has been the subject of several analyst reports. Wells Fargo & Company upped their price objective on Doximity from $25.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Friday, February 9th. Barclays initiated coverage on Doximity in a research note on Wednesday, January 3rd. They issued an “equal weight” rating and a $31.00 price objective for the company. Bank of America upped their price objective on Doximity from $29.00 to $32.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 23rd. Leerink Partnrs reaffirmed a “market perform” rating on shares of Doximity in a report on Monday, February 26th. Finally, SVB Leerink began coverage on shares of Doximity in a report on Monday, February 26th. They issued a “market perform” rating and a $32.00 target price for the company. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Doximity currently has a consensus rating of “Hold” and a consensus target price of $28.00.

Get Our Latest Stock Report on DOCS

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Articles

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.